Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neurosurg

Retrieve available abstracts of 336 articles:
HTML format



Single Articles


    September 2020
  1. NAVARRIA P, Pessina F, Clerici E, Rossini Z, et al
    Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series.
    J Neurosurg. 2020 Sep 4:1-14. doi: 10.3171/2020.5.JNS201116.
    PubMed     Abstract available


    August 2020
  2. WANG L, Chen J
    Letter to the Editor. Feasibility and safety of supratotal resection for low-grade gliomas.
    J Neurosurg. 2020 Aug 28:1-2. doi: 10.3171/2020.7.JNS202601.
    PubMed    


  3. KHALAFALLAH AM, Huq S, Jimenez AE, Brem H, et al
    The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients.
    J Neurosurg. 2020 Aug 14:1-9. doi: 10.3171/2020.5.JNS20766.
    PubMed     Abstract available


    July 2020
  4. STRICKLAND BA, Wedemeyer M, Sizdahkhani S, Giannotta SL, et al
    Letter to the Editor. Management of petroclival meningioma.
    J Neurosurg. 2020 Jul 31:1-3. doi: 10.3171/2020.3.JNS20599.
    PubMed    


  5. YOUNGERMAN BE, Banu MA, Gerges MM, Odigie E, et al
    Endoscopic endonasal approach for suprasellar meningiomas: introduction of a new scoring system to predict extent of resection and assist in case selection with long-term outcome data.
    J Neurosurg. 2020 Jul 24:1-13. doi: 10.3171/2020.4.JNS20475.
    PubMed     Abstract available


  6. FUKUI N, Yawata T, Nakajo T, Kawanishi Y, et al
    Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
    J Neurosurg. 2020 Jul 24:1-11. doi: 10.3171/2020.4.JNS193078.
    PubMed     Abstract available


  7. SPILLE DC, Hess K, Bormann E, Sauerland C, et al
    Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification.
    J Neurosurg. 2020 Jul 17:1-8. doi: 10.3171/2020.4.JNS20412.
    PubMed     Abstract available


  8. BUNEVICIUS A, Lavezzo K, Shabo L, McClure J, et al
    Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
    J Neurosurg. 2020 Jul 10:1-9. doi: 10.3171/2020.4.JNS20788.
    PubMed     Abstract available


    June 2020
  9. ANSARI A
    Letter to the Editor. Awake craniotomy and transcortical MEP monitoring for resection of precentral gliomas.
    J Neurosurg. 2020 Jun 12:1-2. doi: 10.3171/2020.4.JNS201190.
    PubMed    


  10. CHAICHANA KL
    Erratum. Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jun 12:1. doi: 10.3171/2020.5.JNS192466.
    PubMed    


  11. SUI R, Piao H
    Letter to the Editor. Residual meningiomas.
    J Neurosurg. 2020 Jun 12:1-3. doi: 10.3171/2020.2.JNS20447.
    PubMed    


  12. GOGOS AJ, Young JS, Morshed RA, Avalos LN, et al
    Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Jun 5:1-10. doi: 10.3171/2020.3.JNS193434.
    PubMed     Abstract available


  13. GARTON ALA, Kinslow CJ, Wang TJC
    Erratum. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 Jun 5:1. doi: 10.3171/2020.5.JNS192767.
    PubMed    


  14. KONG DS, Kim YH, Hong CK
    Optimal indications and limitations of endoscopic transorbital superior eyelid surgery for spheno-orbital meningiomas.
    J Neurosurg. 2020 Jun 5:1-8. doi: 10.3171/2020.3.JNS20297.
    PubMed     Abstract available


    May 2020
  15. ABI JAOUDE S, Peyre M, Degos V, Goutagny S, et al
    Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    J Neurosurg. 2020 May 22:1-9. doi: 10.3171/2020.3.JNS192382.
    PubMed     Abstract available


  16. JULIE DA, Lazow SP, Vanderbilt DB, Taube S, et al
    A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    J Neurosurg. 2020 May 15:1-8. doi: 10.3171/2020.3.JNS193419.
    PubMed     Abstract available


  17. FATIMA N, Ding VY, Han SS, Chang SD, et al
    Predictors of visual functional outcome following treatment for cavernous sinus meningioma.
    J Neurosurg. 2020 May 15:1-12. doi: 10.3171/2020.2.JNS193009.
    PubMed     Abstract available


  18. BOWDEN GN, Kim JO, Faramand A, Fallon K, et al
    Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases.
    J Neurosurg. 2020 May 8:1-5. doi: 10.3171/2020.3.JNS193369.
    PubMed     Abstract available


  19. GARTON ALA, Kinslow CJ, Rae AI, Mehta A, et al
    Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 May 8:1-11. doi: 10.3171/2020.2.JNS192767.
    PubMed     Abstract available


  20. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Correlation between localization of supratentorial glioma to the precentral gyrus and difficulty in identification of the motor area during awake craniotomy.
    J Neurosurg. 2020 May 1:1-10. doi: 10.3171/2020.2.JNS193471.
    PubMed     Abstract available


  21. MIRCHANDANI AS, Beyh A, Lavrador JP, Howells H, et al
    Altered corticospinal microstructure and motor cortex excitability in gliomas: an advanced tractography and transcranial magnetic stimulation study.
    J Neurosurg. 2020 May 1:1-9. doi: 10.3171/2020.2.JNS192994.
    PubMed     Abstract available


    April 2020
  22. DE VRIES F
    Letter to the Editor. Cognitive performance of patients with low-grade glioma.
    J Neurosurg. 2020 Apr 24:1-2. doi: 10.3171/2020.1.JNS2097.
    PubMed    


  23. LEE AT, Faltermeier C, Morshed RA, Young JS, et al
    The impact of high functional connectivity network hub resection on language task performance in adult low- and high-grade glioma.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS192267.
    PubMed     Abstract available


  24. CHU S
    Erratum. Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2020 Apr 3:1. doi: 10.3171/2020.2.JNS191920.
    PubMed    


  25. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    Quantifying eloquent locations for glioblastoma surgery using resection probability maps.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS193049.
    PubMed     Abstract available


    March 2020
  26. PRZYBYLOWSKI CJ, Zhao X, Baranoski JF, Borba Moreira L, et al
    Preoperative embolization versus no embolization for WHO grade I intracranial meningioma: a retrospective matched cohort study.
    J Neurosurg. 2020 Mar 27:1-8. doi: 10.3171/2020.1.JNS19788.
    PubMed     Abstract available


  27. ZANELLO M, Roux A, Zah-Bi G, Trancart B, et al
    Predictors of early postoperative epileptic seizures after awake surgery in supratentorial diffuse gliomas.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2020.1.JNS192774.
    PubMed     Abstract available


  28. YAMADA T, Tsuji S, Nakamura S, Egashira Y, et al
    Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2019.12.JNS192682.
    PubMed     Abstract available


  29. DALLE ORE CL, Magill ST, Rodriguez Rubio R, Shahin MN, et al
    Hyperostosing sphenoid wing meningiomas: surgical outcomes and strategy for bone resection and multidisciplinary orbital reconstruction.
    J Neurosurg. 2020 Mar 6:1-10. doi: 10.3171/2019.12.JNS192543.
    PubMed     Abstract available


    February 2020
  30. GOLUB D, Hyde J, Dogra S, Nicholson J, et al
    Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis.
    J Neurosurg. 2020 Feb 21:1-15. doi: 10.3171/2019.12.JNS191203.
    PubMed     Abstract available


  31. ISHI Y, Yamaguchi S, Hatanaka KC, Okamoto M, et al
    Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    J Neurosurg. 2020 Feb 14:1-9. doi: 10.3171/2019.12.JNS192155.
    PubMed     Abstract available


  32. YAMASHITA D, Bernstock JD, Elsayed G, Sadahiro H, et al
    Targeting glioma-initiating cells via the tyrosine metabolic pathway.
    J Neurosurg. 2020 Feb 14:1-12. doi: 10.3171/2019.11.JNS192028.
    PubMed     Abstract available


    January 2020
  33. SUERO MOLINA E, Brokinkel B
    Letter to the Editor. Sodium fluorescein versus 5-aminolevulinic acid to visualize high-grade gliomas.
    J Neurosurg. 2020 Jan 24:1-3. doi: 10.3171/2019.12.JNS193180.
    PubMed    


  34. SCHIPMANN S, Muther M, Stogbauer L, Zimmer S, et al
    Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.
    J Neurosurg. 2020 Jan 24:1-11. doi: 10.3171/2019.11.JNS192443.
    PubMed     Abstract available


  35. PRIETO R, Pascual JM
    Cushing's dogged struggle against death: the astonishing case of a patient under cardiac arrest surviving craniopharyngioma surgery.
    J Neurosurg. 2020 Jan 17:1-10. doi: 10.3171/2019.11.JNS192487.
    PubMed     Abstract available


  36. LIU D, Chen J, Hu X, Hu G, et al
    Contralesional homotopic functional plasticity in patients with temporal glioma.
    J Neurosurg. 2020 Jan 10:1-9. doi: 10.3171/2019.11.JNS191982.
    PubMed     Abstract available


  37. MATERI J, Mampre D, Ehresman J, Rincon-Torroella J, et al
    Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jan 3:1-7. doi: 10.3171/2019.10.JNS192466.
    PubMed     Abstract available


  38. PARK SH, Kim MJ, Jung HH, Chang WS, et al
    Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy.
    J Neurosurg. 2020 Jan 3:1-9. doi: 10.3171/2019.10.JNS192206.
    PubMed     Abstract available


    December 2019
  39. BERGER A, Tzarfati G, Costa M, Serafimova M, et al
    Incidence and impact of stroke following surgery for low-grade gliomas.
    J Neurosurg. 2019 Dec 27:1-9. doi: 10.3171/2019.10.JNS192301.
    PubMed     Abstract available


  40. RUSTEMI O, Raneri F, Beggio G, Volpin L, et al
    Letter to the Editor. Cost-effectiveness of sodium fluorescein in high-grade gliomas.
    J Neurosurg. 2019 Dec 13:1-2. doi: 10.3171/2019.10.JNS192817.
    PubMed    


  41. ARRIETA VA, Iwamoto F, Lukas RV, Sachdev S, et al
    Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?
    J Neurosurg. 2019 Dec 6:1-6. doi: 10.3171/2019.9.JNS192523.
    PubMed    


    November 2019
  42. TULEASCA C, Giammattei L, Daniel RT, Levivier M, et al
    Letter to the Editor. Multimodal management for benign skull base meningiomas.
    J Neurosurg. 2019 Nov 15:1-2. doi: 10.3171/2019.6.JNS191682.
    PubMed    


  43. QIU T, Chanchotisatien A, Qin Z, Wu J, et al
    Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2019 Nov 15:1-9. doi: 10.3171/2019.9.JNS191920.
    PubMed     Abstract available


  44. RIJNEN SJM, Kaya G, Gehring K, Verheul JB, et al
    Cognitive functioning in patients with low-grade glioma: effects of hemispheric tumor location and surgical procedure.
    J Neurosurg. 2019 Nov 15:1-12. doi: 10.3171/2019.8.JNS191667.
    PubMed     Abstract available


  45. PRIETO R, Pascual JM, Barrios L
    Charles H. Frazier's craniopharyngioma treatment: the pivotal role of the transfrontal approach.
    J Neurosurg. 2019 Nov 8:1-14. doi: 10.3171/2019.8.JNS191508.
    PubMed     Abstract available


  46. BERNSTEIN A, Mrowczynski OD, Greene A, Ryan S, et al
    Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity.
    J Neurosurg. 2019 Nov 1:1-6. doi: 10.3171/2019.8.JNS19643.
    PubMed     Abstract available


  47. PRIETO R, Pascual JM
    Letter to the Editor. The craniopharyngioma-hypothalamus relationship.
    J Neurosurg. 2019 Nov 1:1-2. doi: 10.3171/2019.7.JNS191780.
    PubMed    


    October 2019
  48. VOGELBAUM MA
    Editorial. Considering the role of surgery for low-grade glioma in the molecular genetic era.
    J Neurosurg. 2019 Oct 25:1-3. doi: 10.3171/2019.7.JNS191747.
    PubMed    


  49. KAVOURIDIS VK, Boaro A, Dorr J, Cho EY, et al
    Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.
    J Neurosurg. 2019 Oct 25:1-11. doi: 10.3171/2019.6.JNS19972.
    PubMed     Abstract available


  50. YOUNGBLOOD MW, Duran D, Montejo JD, Li C, et al
    Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
    J Neurosurg. 2019 Oct 25:1-10. doi: 10.3171/2019.8.JNS191266.
    PubMed     Abstract available


  51. SMITH N, Saunders D, Jensen RL, Towner RA, et al
    Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS182435.
    PubMed     Abstract available


  52. YOMO S, Oda K, Oguchi K
    Single- versus 2-session Gamma Knife surgery for symptomatic midsize brain metastases: a propensity score-matched analysis.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS191193.
    PubMed     Abstract available


  53. IBRAHIM AN, Yamashita D, Anderson JC, Abdelrashid M, et al
    Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.
    J Neurosurg. 2019 Oct 18:1-12. doi: 10.3171/2019.7.JNS191376.
    PubMed     Abstract available


  54. SCHNEIDER M, Guresir A, Borger V, Hamed M, et al
    Preoperative tumor-associated epilepsy in patients with supratentorial meningioma: factors influencing seizure outcome after meningioma surgery.
    J Neurosurg. 2019 Oct 11:1-7. doi: 10.3171/2019.7.JNS19455.
    PubMed     Abstract available


  55. HANSEN RW, Pedersen CB, Halle B, Korshoej AR, et al
    Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.
    J Neurosurg. 2019 Oct 4:1-8. doi: 10.3171/2019.6.JNS191531.
    PubMed     Abstract available


  56. JARVIS CA, Bakhsheshian J, Ding L, Wen T, et al
    Increased complication and mortality among non-index hospital readmissions after brain tumor resection is associated with low-volume readmitting hospitals.
    J Neurosurg. 2019 Oct 4:1-13. doi: 10.3171/2019.6.JNS183469.
    PubMed     Abstract available


    September 2019
  57. MARHOLD F, Mercea PA, Scheichel F, Berghoff AS, et al
    Detailed analysis of 5-aminolevulinic acid induced fluorescence in different brain metastases at two specialized neurosurgical centers: experience in 157 cases.
    J Neurosurg. 2019 Sep 27:1-12. doi: 10.3171/2019.6.JNS1997.
    PubMed     Abstract available


  58. ZHU P, Du XL, Blanco AI, Ballester LY, et al
    Impact of facility type and volume in low-grade glioma outcomes.
    J Neurosurg. 2019 Sep 27:1-11. doi: 10.3171/2019.6.JNS19409.
    PubMed     Abstract available


  59. FECCI PE, Sampson JH
    The current state of immunotherapy for gliomas: an eye toward the future.
    J Neurosurg. 2019;131:657-666.
    PubMed     Abstract available


    August 2019
  60. WANG CH, Qi ST, Fan J, Pan J, et al
    Identification of tumor stem-like cells in admanatimomatous craniopharyngioma and determination of these cells' pathological significance.
    J Neurosurg. 2019 Aug 30:1-11. doi: 10.3171/2019.5.JNS19565.
    PubMed     Abstract available


  61. LAVRADOR JP, Ghimire P, Gullan R, Ashkan K, et al
    Letter to the Editor. Insular glioma surgery.
    J Neurosurg. 2019 Aug 30:1-2. doi: 10.3171/2019.4.JNS19760.
    PubMed    


  62. KIYOFUJI S, Casabella AM, Graffeo CS, Perry A, et al
    Sphenoorbital meningioma: a unique skull base tumor. Surgical technique and results.
    J Neurosurg. 2019 Aug 23:1-8. doi: 10.3171/2019.6.JNS191158.
    PubMed     Abstract available


  63. BERNSTOCK JD, Mooney JH, Ilyas A, Chagoya G, et al
    Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications.
    J Neurosurg. 2019 Aug 23:1-9. doi: 10.3171/2019.5.JNS19364.
    PubMed     Abstract available


  64. DEORA H, Das KK, Jaiswal A, Behari S, et al
    Letter to the Editor. Tumor extension determines approach in insular gliomas.
    J Neurosurg. 2019 Aug 23:1-2. doi: 10.3171/2019.5.JNS191308.
    PubMed    


  65. TAKEI H, Shinoda J, Ikuta S, Maruyama T, et al
    Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.
    J Neurosurg. 2019 Aug 16:1-10. doi: 10.3171/2019.5.JNS19780.
    PubMed     Abstract available


  66. KIM KH, Kong DS, Cho KR, Lee MH, et al
    Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study.
    J Neurosurg. 2019 Aug 16:1-10. doi: 10.3171/2019.5.JNS19222.
    PubMed     Abstract available


  67. INCEKARA F, Smits M, Vincent AJPE
    Letter to the Editor. Supratotal resection of glioblastoma.
    J Neurosurg. 2019 Aug 16:1-2. doi: 10.3171/2019.3.JNS19810.
    PubMed    


  68. BUTOWSKI NA, Bringas JR, Bankiewicz KS, Aghi MK, et al
    Editorial. Chronic convection-enhanced delivery: the next frontier in regional drug infusion for glioblastoma.
    J Neurosurg. 2019 Aug 2:1-3. doi: 10.3171/2019.4.JNS19614.
    PubMed    


  69. ZHAO X, Belykh E, Przybylowski CJ, Borba Moreira L, et al
    Surgical treatment of falcotentorial meningiomas: a retrospective review of a single-institution experience.
    J Neurosurg. 2019 Aug 2:1-12. doi: 10.3171/2019.4.JNS19208.
    PubMed     Abstract available


    July 2019
  70. CAPLAN IF, Glauser G, Goodrich S, Chen HI, et al
    Undiagnosed obstructive sleep apnea as a predictor of 30-day readmission for brain tumor patients.
    J Neurosurg. 2019 Jul 19:1-6. doi: 10.3171/2019.4.JNS1968.
    PubMed     Abstract available


  71. PALA A, Coburger J, Scherer M, Ahmeti H, et al
    To treat or not to treat? A retrospective multicenter assessment of survival in patients with IDH-mutant low-grade glioma based on adjuvant treatment.
    J Neurosurg. 2019 Jul 19:1-8. doi: 10.3171/2019.4.JNS183395.
    PubMed     Abstract available


  72. PRIETO R, Pascual JM
    Letter to the Editor. Heterogeneous hypothalamic adhesion among third ventricle craniopharyngiomas.
    J Neurosurg. 2019 Jul 19:1-2. doi: 10.3171/2019.3.JNS19755.
    PubMed    


    June 2019
  73. JENKINSON MD, Ali A, Islim AI, Helmy A, et al
    Letter to the Editor. Establishing the role of prophylactic antiepileptic drugs in glioma and meningioma surgery.
    J Neurosurg. 2019 Jun 28:1-3. doi: 10.3171/2019.1.JNS19134.
    PubMed    


  74. LEE CC, Hsu SPC, Lin CJ, Wu HM, et al
    Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non-small cell lung cancer and brain metastases.
    J Neurosurg. 2019 Jun 21:1-8. doi: 10.3171/2019.4.JNS19446.
    PubMed     Abstract available


  75. BUTSCHEIDT S, Ernst M, Rolvien T, Hubert J, et al
    Primary intraosseous meningioma: clinical, histological, and differential diagnostic aspects.
    J Neurosurg. 2019 Jun 21:1-10. doi: 10.3171/2019.3.JNS182968.
    PubMed     Abstract available


  76. CHANDRA A, Young JS, Dalle Ore C, Dayani F, et al
    Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma.
    J Neurosurg. 2019 Jun 21:1-11. doi: 10.3171/2019.3.JNS182629.
    PubMed     Abstract available


  77. HAAPALA I, Karjalainen M, Kontunen A, Vehkaoja A, et al
    Identifying brain tumors by differential mobility spectrometry analysis of diathermy smoke.
    J Neurosurg. 2019 Jun 14:1-7. doi: 10.3171/2019.3.JNS19274.
    PubMed     Abstract available


  78. RAFFA G, Picht T, Scibilia A, Rosler J, et al
    Surgical treatment of meningiomas located in the rolandic area: the role of navigated transcranial magnetic stimulation for preoperative planning, surgical strategy, and prediction of arachnoidal cleavage and motor outcome.
    J Neurosurg. 2019 Jun 14:1-12. doi: 10.3171/2019.3.JNS183411.
    PubMed     Abstract available


  79. PRIETO R, Pascual JM
    Percival S. Bailey: eminent scholar of neurosciences who revealed the workings of the hypothalamus through clinicopathological research on craniopharyngiomas.
    J Neurosurg. 2019 Jun 14:1-13. doi: 10.3171/2019.3.JNS183145.
    PubMed     Abstract available


  80. TANG B, Xie S, Huang G, Wang Z, et al
    Clinical features and operative technique of transinfundibular craniopharyngioma.
    J Neurosurg. 2019 Jun 14:1-10. doi: 10.3171/2019.3.JNS181953.
    PubMed     Abstract available


  81. TERPOLILLI NA, Ueberschaer M, Niyazi M, Hintschich C, et al
    Long-term outcome in orbital meningiomas: progression-free survival after targeted resection combined with early or postponed postoperative radiotherapy.
    J Neurosurg. 2019 Jun 14:1-11. doi: 10.3171/2019.3.JNS181760.
    PubMed     Abstract available


    May 2019
  82. ALMIRON BONNIN DA, Havrda MC, Lee MC, Evans L, et al
    Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma.
    J Neurosurg. 2019 May 24:1-9. doi: 10.3171/2019.2.JNS183128.
    PubMed     Abstract available


  83. KIM JH, Moon KS, Jung JH, Jang WY, et al
    Importance of collateral venous circulation on indocyanine green videoangiography in intracranial meningioma resection: direct evidence for venous compression theory in peritumoral edema formation.
    J Neurosurg. 2019 May 24:1-9. doi: 10.3171/2019.3.JNS182308.
    PubMed     Abstract available


  84. MOTOMURA K, Chalise L, Ohka F, Aoki K, et al
    Neurocognitive and functional outcomes in patients with diffuse frontal lower-grade gliomas undergoing intraoperative awake brain mapping.
    J Neurosurg. 2019 May 17:1-9. doi: 10.3171/2019.3.JNS19211.
    PubMed     Abstract available


  85. ROSSI M, Ambrogi F, Gay L, Gallucci M, et al
    Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome.
    J Neurosurg. 2019 May 17:1-14. doi: 10.3171/2019.2.JNS183408.
    PubMed     Abstract available


  86. GUO X, Yao S, Xing B
    Letter to the Editor. Is 7-Tesla MRI necessary in the assessment of microstructural injury to visual pathways due to pituitary adenomas?
    J Neurosurg. 2019 May 17:1-3. doi: 10.3171/2019.2.JNS19413.
    PubMed    


  87. KIM JW, Jung HW, Kim YH, Park CK, et al
    Petroclival meningiomas: long-term outcomes of multimodal treatments and management strategies based on 30 years of experience at a single institution.
    J Neurosurg. 2019 May 10:1-8. doi: 10.3171/2019.2.JNS182604.
    PubMed     Abstract available


  88. WIDHALM G, Olson J, Weller J, Bravo J, et al
    The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.
    J Neurosurg. 2019 May 10:1-10. doi: 10.3171/2019.1.JNS182614.
    PubMed     Abstract available


    April 2019
  89. SUERO MOLINA E, Ewelt C, Warneke N, Schwake M, et al
    Dual labeling with 5-aminolevulinic acid and fluorescein in high-grade glioma surgery with a prototype filter system built into a neurosurgical microscope: technical note.
    J Neurosurg. 2019 Apr 26:1-7. doi: 10.3171/2018.12.JNS182422.
    PubMed     Abstract available


  90. SERIZAWA T, Yamamoto M, Higuchi Y, Sato Y, et al
    Local tumor progression treated with Gamma Knife radiosurgery: differences between patients with 2-4 versus 5-10 brain metastases based on an update of a multi-institutional prospective observational study (JLGK0901).
    J Neurosurg. 2019 Apr 26:1-10. doi: 10.3171/2019.1.JNS183085.
    PubMed     Abstract available


  91. LI C, Wang S, Yan JL, Torheim T, et al
    Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging.
    J Neurosurg. 2019 Apr 26:1-8. doi: 10.3171/2018.12.JNS182926.
    PubMed     Abstract available


  92. GUPTA N
    Editorial. Patient outcomes following treatment for craniopharyngioma.
    J Neurosurg. 2019 Apr 19:1-2. doi: 10.3171/2018.12.JNS182943.
    PubMed    


  93. LAN F, Qin Q, Yu H, Yue X, et al
    Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity.
    J Neurosurg. 2019 Apr 19:1-9. doi: 10.3171/2018.12.JNS181798.
    PubMed     Abstract available


  94. GIESE H, Haenig B, Haenig A, Unterberg A, et al
    Neurological and neuropsychological outcome after resection of craniopharyngiomas.
    J Neurosurg. 2019 Apr 19:1-10. doi: 10.3171/2018.10.JNS181557.
    PubMed     Abstract available


  95. ULGEN E, Can O, Bilguvar K, Oktay Y, et al
    Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
    J Neurosurg. 2019 Apr 5:1-12. doi: 10.3171/2019.1.JNS182938.
    PubMed     Abstract available


  96. PRZYBYLOWSKI CJ, Baranoski JF, So VM, Wilson J, et al
    Surgical morbidity of transsylvian versus transcortical approaches to insular gliomas.
    J Neurosurg. 2019 Apr 5:1-8. doi: 10.3171/2018.12.JNS183075.
    PubMed     Abstract available


  97. LIN Z, Jiang Z
    Erratum. Clinical characteristics of and treatment protocol for trapped temporal horn following resection of lateral ventricular trigone meningioma: a single-center experience.
    J Neurosurg. 2019 Apr 5:1. doi: 10.3171/2019.3.JNS182710.
    PubMed    


  98. HAN EY, Wang H, Luo D, Li J, et al
    Dosimetric comparison of fractionated radiosurgery plans using frameless Gamma Knife ICON and CyberKnife systems with linear accelerator-based radiosurgery plans for multiple large brain metastases.
    J Neurosurg. 2019 Apr 5:1-7. doi: 10.3171/2019.1.JNS182769.
    PubMed     Abstract available


  99. DALLE ORE CL, Magill ST, Yen AJ, Shahin MN, et al
    Meningioma metastases: incidence and proposed screening paradigm.
    J Neurosurg. 2019 Apr 5:1-9. doi: 10.3171/2019.1.JNS181771.
    PubMed     Abstract available


  100. HANALIOGLU S, Sahin B, Sahin OS, Kozan A, et al
    Effect of perioperative aspirin use on hemorrhagic complications in elective craniotomy for brain tumors: results of a single-center, retrospective cohort study.
    J Neurosurg. 2019 Apr 5:1-10. doi: 10.3171/2018.12.JNS182483.
    PubMed     Abstract available


    March 2019
  101. WILDE H, Azab MA, Abunimer AM, Abou-Al-Shaar H, et al
    Evaluation of cost and survival in intracranial gliomas using the Value Driven Outcomes database: a retrospective cohort analysis.
    J Neurosurg. 2019 Mar 29:1-11. doi: 10.3171/2018.12.JNS183109.
    PubMed     Abstract available


  102. CHOI BD, Lee DK, Yang JC, Ayinon CM, et al
    Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.
    J Neurosurg. 2019 Mar 29:1-7. doi: 10.3171/2018.12.JNS182700.
    PubMed     Abstract available


  103. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas in the precentral gyrus: utility for predicting motor function.
    J Neurosurg. 2019 Mar 15:1-11. doi: 10.3171/2018.11.JNS182609.
    PubMed     Abstract available


  104. WANG W, Swenson S, Cho HY, Hofman FM, et al
    Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models.
    J Neurosurg. 2019 Mar 15:1-9. doi: 10.3171/2018.11.JNS181161.
    PubMed     Abstract available


  105. ROH TH, Kang SG, Moon JH, Sung KS, et al
    Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study.
    J Neurosurg. 2019 Mar 1:1-7. doi: 10.3171/2018.12.JNS182558.
    PubMed     Abstract available


  106. SHAFIQ AR, Wernicke AG, Riley CA, Morgenstern PF, et al
    Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note.
    J Neurosurg. 2019 Mar 1:1-6. doi: 10.3171/2018.11.JNS181943.
    PubMed     Abstract available


    February 2019
  107. SINGH C, Qian JM, Yu JB, Chiang VL, et al
    Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    J Neurosurg. 2019 Feb 15:1-6. doi: 10.3171/2018.10.JNS181371.
    PubMed     Abstract available


  108. ZHU P, Du XL, Zhu JJ, Esquenazi Y, et al
    Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
    J Neurosurg. 2019 Feb 15:1-12. doi: 10.3171/2018.10.JNS182247.
    PubMed     Abstract available


  109. GOZAL YM, Alzhrani G, Abou-Al-Shaar H, Azab MA, et al
    Outcomes of decompressive surgery for cavernous sinus meningiomas: long-term follow-up in 50 patients.
    J Neurosurg. 2019 Feb 15:1-8. doi: 10.3171/2018.10.JNS181480.
    PubMed     Abstract available


  110. LIN Z, Wang C, Gao Z, Li X, et al
    Clinical characteristics of and treatment protocol for trapped temporal horn following resection of lateral ventricular trigone meningioma: a single-center experience.
    J Neurosurg. 2019 Feb 15:1-10. doi: 10.3171/2018.11.JNS182710.
    PubMed     Abstract available


  111. PARSAI S, Miller JA, Juloori A, Chao ST, et al
    Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
    J Neurosurg. 2019 Feb 8:1-9. doi: 10.3171/2018.10.JNS182340.
    PubMed     Abstract available


  112. KATSEVMAN GA, Turner RC, Urhie O, Voelker JL, et al
    Utility of sodium fluorescein for achieving resection targets in glioblastoma: increased gross- or near-total resections and prolonged survival.
    J Neurosurg. 2019 Feb 8:1-7. doi: 10.3171/2018.10.JNS181174.
    PubMed     Abstract available


  113. BO HK, Solheim O, Kvistad KA, Berntsen EM, et al
    Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    J Neurosurg. 2019 Feb 1:1-12. doi: 10.3171/2018.10.JNS181290.
    PubMed     Abstract available


  114. KO CC, Chen TY, Lim SW, Kuo YT, et al
    Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
    J Neurosurg. 2019 Feb 1:1-9. doi: 10.3171/2018.10.JNS181783.
    PubMed     Abstract available


    January 2019
  115. WHITING BB, Lee BS, Mahadev V, Borghei-Razavi H, et al
    Combined use of minimal access craniotomy, intraoperative magnetic resonance imaging, and awake functional mapping for the resection of gliomas in 61 patients.
    J Neurosurg. 2019 Jan 25:1-9. doi: 10.3171/2018.9.JNS181802.
    PubMed     Abstract available


  116. MINCHEV G, Kronreif G, Ptacek W, Dorfer C, et al
    A novel robot-guided minimally invasive technique for brain tumor biopsies.
    J Neurosurg. 2019 Jan 18:1-9. doi: 10.3171/2018.8.JNS182096.
    PubMed     Abstract available


  117. JULOORI A, Miller JA, Parsai S, Kotecha R, et al
    Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
    J Neurosurg. 2019 Jan 18:1-9. doi: 10.3171/2018.8.JNS182100.
    PubMed     Abstract available


  118. RUTLAND JW, Padormo F, Yim CK, Yao A, et al
    Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
    J Neurosurg. 2019 Jan 18:1-10. doi: 10.3171/2018.9.JNS182022.
    PubMed     Abstract available


  119. WAGNER A, Shiban Y, Lange N, Joerger AK, et al
    The relevant psychological burden of having a benign brain tumor: a prospective study of patients undergoing surgical treatment of cranial meningiomas.
    J Neurosurg. 2019 Jan 11:1-8. doi: 10.3171/2018.8.JNS181343.
    PubMed     Abstract available


  120. CHEN CH, Chen PY, Lin YY, Feng LY, et al
    Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma.
    J Neurosurg. 2019 Jan 11:1-12. doi: 10.3171/2018.8.JNS181217.
    PubMed     Abstract available


  121. ALFARO CM, Pirro V, Keating MF, Hattab EM, et al
    Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry.
    J Neurosurg. 2019 Jan 4:1-8. doi: 10.3171/2018.8.JNS181207.
    PubMed     Abstract available


  122. RINALDO L, Brown DA, Bhargav AG, Rusheen AE, et al
    Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    J Neurosurg. 2019 Jan 4:1-12. doi: 10.3171/2018.7.JNS181175.
    PubMed     Abstract available


  123. HERVEY-JUMPER SL, Berger MS
    Insular glioma surgery: an evolution of thought and practice.
    J Neurosurg. 2019;130:9-16.
    PubMed     Abstract available


    December 2018
  124. SHEEHAN JP, Grills I, Chiang VL, Dong H, et al
    Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry.
    J Neurosurg. 2018 Dec 21:1-7. doi: 10.3171/2018.8.JNS181599.
    PubMed     Abstract available


  125. TAKAMI H, Prummer CM, Graffeo CS, Peris-Celda M, et al
    Glioblastoma of the cerebellopontine angle and internal auditory canal mimicking a peripheral nerve sheath tumor: case report.
    J Neurosurg. 2018 Dec 21:1-5. doi: 10.3171/2018.8.JNS181702.
    PubMed     Abstract available


  126. BRACHMAN DG, Youssef E, Dardis CJ, Sanai N, et al
    Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    J Neurosurg. 2018 Dec 21:1-10. doi: 10.3171/2018.7.JNS18656.
    PubMed     Abstract available


  127. MUNIER SM, Hargreaves EL, Patel NV, Danish SF, et al
    Ablation dynamics of subsequent thermal doses delivered to previously heat-damaged tissue during magnetic resonance-guided laser-induced thermal therapy.
    J Neurosurg. 2018 Dec 21:1-8. doi: 10.3171/2018.7.JNS18886.
    PubMed     Abstract available



  128. Prospective clinical validation of a meningioma consistency grading scheme: association with surgical outcomes and extent of tumor resection.
    J Neurosurg. 2018 Dec 14:1-5. doi: 10.3171/2018.7.JNS1838.
    PubMed     Abstract available



  129. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
    J Neurosurg. 2018 Dec 14:1-8. doi: 10.3171/2018.7.JNS181293.
    PubMed     Abstract available



  130. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas.
    J Neurosurg. 2018 Dec 14:1-11. doi: 10.3171/2018.7.JNS181642.
    PubMed     Abstract available



  131. Letter to the Editor. Preoperative seizures as predictive sign of brain invasion by meningioma.
    J Neurosurg. 2018 Dec 1:1-3. doi: 10.3171/2018.10.JNS182851.
    PubMed    



  132. Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma.
    J Neurosurg. 2018 Dec 1:1-8. doi: 10.3171/2018.7.JNS18422.
    PubMed     Abstract available



  133. Pretreatment texture analysis of routine MR images and shape analysis of the diffusion tensor for prediction of volumetric response after radiosurgery for meningioma.
    J Neurosurg. 2018;129.
    PubMed     Abstract available



  134. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
    J Neurosurg. 2018;129.
    PubMed     Abstract available



  135. Hearing preservation after Gamma Knife radiosurgery for cerebellopontine angle meningiomas.
    J Neurosurg. 2018;129.
    PubMed     Abstract available



  136. Three-stage Gamma Knife treatment for metastatic brain tumors larger than 10 cm3: a 2-institute study including re-analyses of earlier results using competing risk analysis.
    J Neurosurg. 2018;129.
    PubMed     Abstract available



  137. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    J Neurosurg. 2018;129.
    PubMed     Abstract available


    November 2018

  138. Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas.
    J Neurosurg. 2018 Nov 1:1-9. doi: 10.3171/2018.6.JNS18901.
    PubMed     Abstract available



  139. Endonasal endoscopic transsphenoidal resection of intrinsic third ventricular craniopharyngioma: surgical results.
    J Neurosurg. 2018 Nov 1:1-11. doi: 10.3171/2018.5.JNS18198.
    PubMed     Abstract available



  140. Surgical outcomes after reoperation for recurrent non-skull base meningiomas.
    J Neurosurg. 2018 Nov 1:1-9. doi: 10.3171/2018.6.JNS18118.
    PubMed     Abstract available



  141. Survival effects of a strategy favoring second-line multimodal treatment compared to supportive care in glioblastoma patients at first progression.
    J Neurosurg. 2018 Nov 1:1-6. doi: 10.3171/2018.7.JNS18228.
    PubMed     Abstract available


    October 2018

  142. Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18153.
    PubMed     Abstract available



  143. Harvey Cushing's craniopharyngioma treatment: Part 2. Surgical strategies and results of his pioneering series.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18154.
    PubMed     Abstract available



  144. Transcortical insular glioma resection: clinical outcome and predictors.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS18424.
    PubMed     Abstract available



  145. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
    J Neurosurg. 2018 Oct 1:1-7. doi: 10.3171/2018.5.JNS18340.
    PubMed     Abstract available



  146. A modern series of subdiaphragmatic craniopharyngiomas.
    J Neurosurg. 2018 Oct 1:1-6. doi: 10.3171/2018.4.JNS172330.
    PubMed     Abstract available



  147. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS172909.
    PubMed     Abstract available



  148. ReStNeuMap: a tool for automatic extraction of resting-state functional MRI networks in neurosurgical practice.
    J Neurosurg. 2018 Oct 1:1-8. doi: 10.3171/2018.4.JNS18474.
    PubMed     Abstract available


    September 2018
  149. LAVRADOR JP, Acharya S, Giamouriadis A, Vergani F, et al
    Letter to the Editor. Intermediate-risk meningioma and NRG Oncology RTOG 0539.
    J Neurosurg. 2018 Sep 28:1-3. doi: 10.3171/2018.4.JNS18811.
    PubMed    


  150. PUGLISI G, Sciortino T, Rossi M, Leonetti A, et al
    Preserving executive functions in nondominant frontal lobe glioma surgery: an intraoperative tool.
    J Neurosurg. 2018 Sep 28:1-7. doi: 10.3171/2018.4.JNS18393.
    PubMed     Abstract available


  151. MORSHED RA, Young JS, Han SJ, Hervey-Jumper SL, et al
    Perioperative outcomes following reoperation for recurrent insular gliomas.
    J Neurosurg. 2018 Sep 21:1-7. doi: 10.3171/2018.4.JNS18375.
    PubMed     Abstract available


  152. RASSI MS, Prasad S, Can A, Pravdenkova S, et al
    Prognostic factors in the surgical treatment of intracanalicular primary optic nerve sheath meningiomas.
    J Neurosurg. 2018 Sep 21:1-8. doi: 10.3171/2018.4.JNS173080.
    PubMed     Abstract available


  153. HIRATA T, Kinoshita M, Tamari K, Seo Y, et al
    (11)C-methionine-(18)F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
    J Neurosurg. 2018 Sep 21:1-11. doi: 10.3171/2018.4.JNS1859.
    PubMed     Abstract available


  154. MUHLESTEIN WE, Akagi DS, McManus AR, Chambless LB, et al
    Machine learning ensemble models predict total charges and drivers of cost for transsphenoidal surgery for pituitary tumor.
    J Neurosurg. 2018 Sep 21:1-10. doi: 10.3171/2018.4.JNS18306.
    PubMed     Abstract available


  155. SUNDBLOM J, Nowinski D, Casar-Borota O, Ryttlefors M, et al
    Removal of giant intraosseous meningioma followed by cranioplasty using a custom-made bioceramic implant: case report.
    J Neurosurg. 2018 Sep 14:1-5. doi: 10.3171/2018.4.JNS1850.
    PubMed     Abstract available


  156. FOLARON M, Strawbridge R, Samkoe KS, Filan C, et al
    Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
    J Neurosurg. 2018 Sep 7:1-11. doi: 10.3171/2018.4.JNS172644.
    PubMed     Abstract available


  157. SERIZAWA T, Higuchi Y, Yamamoto M, Matsunaga S, et al
    Comparison of treatment results between 3- and 2-stage Gamma Knife radiosurgery for large brain metastases: a retrospective multi-institutional study.
    J Neurosurg. 2018 Sep 7:1-11. doi: 10.3171/2018.4.JNS172596.
    PubMed     Abstract available



  158. Erratum. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    J Neurosurg. 2018 Sep 1:1. doi: 10.3171/2018.8.JNS161170.
    PubMed    


    August 2018
  159. JENKINSON MD, Weber DC, Haylock BJ, Sherratt FC, et al
    Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma.
    J Neurosurg. 2018 Aug 17:1-2. doi: 10.3171/2018.6.JNS181418.
    PubMed    


  160. HAN SJ, Morshed RA, Troncon I, Jordan KM, et al
    Subcortical stimulation mapping of descending motor pathways for perirolandic gliomas: assessment of morbidity and functional outcome in 702 cases.
    J Neurosurg. 2018 Aug 17:1-8. doi: 10.3171/2018.3.JNS172494.
    PubMed     Abstract available


  161. BROKINKEL B, Sicking J, Spille DC, Hess K, et al
    Letter to the Editor. Brain invasion and the risk for postoperative hemorrhage and neurological deterioration after meningioma surgery.
    J Neurosurg. 2018 Aug 10:1-3. doi: 10.3171/2018.5.JNS181287.
    PubMed    


  162. MASUDA Y, Akutsu H, Ishikawa E, Matsuda M, et al
    Evaluation of the extent of resection and detection of ischemic lesions with intraoperative MRI in glioma surgery: is intraoperative MRI superior to early postoperative MRI?
    J Neurosurg. 2018 Aug 10:1-8. doi: 10.3171/2018.3.JNS172516.
    PubMed     Abstract available


  163. HARA T, Akutsu H, Takano S, Kino H, et al
    Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation.
    J Neurosurg. 2018 Aug 3:1-10. doi: 10.3171/2018.3.JNS172528.
    PubMed     Abstract available



  164. Erratum. A prospective randomized trial of the optimal dose of mannitol for intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.
    J Neurosurg. 2018;129:551-552.
    PubMed    


    July 2018
  165. SCHERER M, Jungk C, Gotz M, Kickingereder P, et al
    Early postoperative delineation of residual tumor after low-grade glioma resection by probabilistic quantification of diffusion-weighted imaging.
    J Neurosurg. 2018 Jul 27:1-9. doi: 10.3171/2018.2.JNS172951.
    PubMed     Abstract available


  166. PARK KJ, Kano H, Iyer A, Liu X, et al
    Gamma Knife stereotactic radiosurgery for cavernous sinus meningioma: long-term follow-up in 200 patients.
    J Neurosurg. 2018 Jul 20:1-10. doi: 10.3171/2018.2.JNS172361.
    PubMed     Abstract available


    June 2018
  167. LAGMAN C, Ong V, Nguyen T, Alkhalid Y, et al
    The Meningioma Vascularity Index: a volumetric analysis of flow voids to predict intraoperative blood loss in nonembolized meningiomas.
    J Neurosurg. 2018 Jun 22:1-6. doi: 10.3171/2018.1.JNS172724.
    PubMed     Abstract available


  168. INCEKARA F, Satoer D, Visch-Brink E, Vincent A, et al
    Changes in language white matter tract microarchitecture associated with cognitive deficits in patients with presumed low-grade glioma.
    J Neurosurg. 2018 Jun 8:1-9. doi: 10.3171/2017.12.JNS171681.
    PubMed     Abstract available


  169. HIDALGO ET, McQuinn MW, Wisoff JH
    Regression after subtotal resection of an optic pathway glioma in an adult without adjuvant therapy: case report.
    J Neurosurg. 2018 Jun 1:1-4. doi: 10.3171/2017.12.JNS172188.
    PubMed     Abstract available


  170. KONG B, Liu Y
    Letter to the Editor. How to provide intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.
    J Neurosurg. 2018 Jun 1:1-2. doi: 10.3171/2017.8.JNS172025.
    PubMed    


    May 2018
  171. OTTENHAUSEN M, Rumalla K, Younus I, Minkowitz S, et al
    Predictors of postoperative motor function in rolandic meningiomas.
    J Neurosurg. 2018 May 25:1-6. doi: 10.3171/2017.12.JNS172423.
    PubMed     Abstract available


  172. AGARWAL N, Gupta D
    Letter to the Editor. Endoscopic endonasal versus transcranial approach to tuberculum sellae and planum sphenoidale meningiomas: unanswered questions.
    J Neurosurg. 2018 May 25:1-2. doi: 10.3171/2018.3.JNS18598.
    PubMed    


  173. MARX S, Schroeder HWS
    Letter to the Editor. Transcranial versus endonasal approaches in tuberculum sellae meningioma surgery.
    J Neurosurg. 2018 May 25:1-2. doi: 10.3171/2018.2.JNS18282.
    PubMed    


  174. KIM KH, Kang SJ, Choi JW, Kong DS, et al
    Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention.
    J Neurosurg. 2018 May 18:1-10. doi: 10.3171/2017.12.JNS171943.
    PubMed     Abstract available


  175. KONG DS, Hong CK, Hong SD, Nam DH, et al
    Selection of endoscopic or transcranial surgery for tuberculum sellae meningiomas according to specific anatomical features: a retrospective multicenter analysis (KOSEN-002).
    J Neurosurg. 2018 May 18:1-10. doi: 10.3171/2017.11.JNS171337.
    PubMed     Abstract available


  176. LIN M, Wedemeyer MA, Bradley D, Donoho DA, et al
    Long-term surgical outcomes following transsphenoidal surgery in patients with Rathke's cleft cysts.
    J Neurosurg. 2018 May 18:1-7. doi: 10.3171/2017.11.JNS171498.
    PubMed     Abstract available


  177. PRIETO R, Pascual JM, Barrios L
    Letter to the Editor. The role of preoperative MRI in predicting craniopharyngioma behavior.
    J Neurosurg. 2018 May 4:1-3. doi: 10.3171/2017.11.JNS172880.
    PubMed    


  178. AHLUWALIA M, Barnett GH, Deng D, Tatter SB, et al
    Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.
    J Neurosurg. 2018 May 4:1-8. doi: 10.3171/2017.11.JNS171273.
    PubMed     Abstract available


  179. MAGILL ST, Lee DS, Yen AJ, Lucas CG, et al
    Surgical outcomes after reoperation for recurrent skull base meningiomas.
    J Neurosurg. 2018 May 4:1-8. doi: 10.3171/2017.11.JNS172278.
    PubMed     Abstract available


  180. LIOUTA E, Stranjalis G, Kalyvas AV, Koutsarnakis C, et al
    Parietal association deficits in patients harboring parietal lobe gliomas: a prospective study.
    J Neurosurg. 2018 May 4:1-7. doi: 10.3171/2017.12.JNS171799.
    PubMed     Abstract available


  181. YAMASHITA S, Yokogami K, Matsumoto F, Saito K, et al
    MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
    J Neurosurg. 2018 May 4:1-9. doi: 10.3171/2017.11.JNS171710.
    PubMed     Abstract available


  182. WANG Z, Xing B
    Letter to the Editor. Detection of MRI-negative Cushing's disease by FLAIR imaging: is it reliable?
    J Neurosurg. 2018 May 4:1-2. doi: 10.3171/2017.12.JNS173041.
    PubMed    


    April 2018
  183. HIMES BT, Ruff MW, Van Gompel JJ, Park SS, et al
    Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report.
    J Neurosurg. 2018 Apr 27:1-5. doi: 10.3171/2017.11.JNS172373.
    PubMed     Abstract available


  184. LIU F, Chen W, Chen J
    Letter to the Editor. Resection for WHO Grade III gliomas.
    J Neurosurg. 2018 Apr 27:1-2. doi: 10.3171/2017.10.JNS172459.
    PubMed    


  185. HESS K, Spille DC, Adeli A, Sporns PB, et al
    Brain invasion and the risk of seizures in patients with meningioma.
    J Neurosurg. 2018 Apr 27:1-8. doi: 10.3171/2017.11.JNS172265.
    PubMed     Abstract available


  186. MORSHED RA, Young JS, Han SJ, Hervey-Jumper SL, et al
    The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes.
    J Neurosurg. 2018 Apr 20:1-9. doi: 10.3171/2017.10.JNS172055.
    PubMed     Abstract available


  187. JHAVERI J, Chowdhary M, Zhang X, Press RH, et al
    Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.9.JNS171735.
    PubMed     Abstract available


  188. SIVAKUMAR W, Jensen M, Martinez J, Tanana M, et al
    Intravenous acetaminophen for postoperative supratentorial craniotomy pain: a prospective, randomized, double-blinded, placebo-controlled trial.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.10.JNS171464.
    PubMed     Abstract available


  189. VOGELBAUM MA, Brewer C, Barnett GH, Mohammadi AM, et al
    First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.
    J Neurosurg. 2018 Apr 13:1-10. doi: 10.3171/2017.10.JNS171845.
    PubMed     Abstract available


  190. BASHIR A, Brennum J, Broholm H, Law I, et al
    The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[(18)F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    J Neurosurg. 2018 Apr 6:1-14. doi: 10.3171/2017.8.JNS171577.
    PubMed     Abstract available


  191. CHEN WC, Magill ST, Wu A, Vasudevan HN, et al
    Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    J Neurosurg. 2018 Apr 6:1-8. doi: 10.3171/2017.9.JNS171609.
    PubMed     Abstract available


    March 2018
  192. AMELOT A, van Effenterre R, Kalamarides M, Cornu P, et al
    Natural history of cavernous sinus meningiomas.
    J Neurosurg. 2018 Mar 30:1-8. doi: 10.3171/2017.7.JNS17662.
    PubMed     Abstract available


  193. BARZILAI O, Ben Moshe S, Sitt R, Sela G, et al
    Improvement in cognitive function after surgery for low-grade glioma.
    J Neurosurg. 2018 Mar 23:1-9. doi: 10.3171/2017.9.JNS17658.
    PubMed     Abstract available


  194. KARSY M, Guan J, Huang LE
    Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
    J Neurosurg. 2018 Mar 16:1-11. doi: 10.3171/2017.9.JNS172036.
    PubMed     Abstract available


  195. LI D, Jiao YM, Wang L, Lin FX, et al
    Surgical outcome of motor deficits and neurological status in brainstem cavernous malformations based on preoperative diffusion tensor imaging: a prospective randomized clinical trial.
    J Neurosurg. 2018 Mar 16:1-16. doi: 10.3171/2017.8.JNS17854.
    PubMed     Abstract available


  196. KUROGI R, Nakamizo A, Suzuki SO, Mizoguchi M, et al
    Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
    J Neurosurg. 2018 Mar 9:1-12. doi: 10.3171/2017.8.JNS1788.
    PubMed     Abstract available


    February 2018
  197. ROSSI M, Fornia L, Puglisi G, Leonetti A, et al
    Assessment of the praxis circuit in glioma surgery to reduce the incidence of postoperative and long-term apraxia: a new intraoperative test.
    J Neurosurg. 2018 Feb 23:1-11. doi: 10.3171/2017.7.JNS17357.
    PubMed     Abstract available


  198. WANG L, Chen W, Liu F, Zhang LF, et al
    Letter to the Editor. Multiple meningiomas.
    J Neurosurg. 2018 Feb 23:1-2. doi: 10.3171/2017.8.JNS172004.
    PubMed    


  199. VAN BAARSEN K, Roth J, Serova N, Packer RJ, et al
    Optic pathway-hypothalamic glioma hemorrhage: a series of 9 patients and review of the literature.
    J Neurosurg. 2018 Feb 9:1-9. doi: 10.3171/2017.8.JNS163085.
    PubMed     Abstract available


    January 2018
  200. SADIK ZHA, Lie ST, Leenstra S, Hanssens PEJ, et al
    Volumetric changes and clinical outcome for petroclival meningiomas after primary treatment with Gamma Knife radiosurgery.
    J Neurosurg. 2018 Jan 26:1-7. doi: 10.3171/2017.7.JNS17380.
    PubMed     Abstract available


  201. LIU F, Chen W, Chen J
    Letter to the Editor. Is there any relationship between estrogen receptor/progesterone receptor status and recurrence of meningioma?
    J Neurosurg. 2018 Jan 26:1-3. doi: 10.3171/2017.9.JNS172219.
    PubMed    


  202. XUE FS, Yang GZ, Li HX, Liu YY, et al
    Letter to the Editor. Is preoperative hypoalbuminemia really a risk factor associated with acute kidney injury and mortality after brain tumor surgery?
    J Neurosurg. 2018 Jan 19:1-3. doi: 10.3171/2017.7.JNS171654.
    PubMed    


  203. SHAKIR SI, Souhami L, Petrecca K, Mansure JJ, et al
    Prognostic factors for progression in atypical meningioma.
    J Neurosurg. 2018 Jan 19:1-9. doi: 10.3171/2017.6.JNS17120.
    PubMed     Abstract available


  204. SUEHIRO S, Ohnishi T, Yamashita D, Kohno S, et al
    Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
    J Neurosurg. 2018 Jan 19:1-13. doi: 10.3171/2017.6.JNS162398.
    PubMed     Abstract available


  205. LUEDI MM, Singh SK, Mosley JC, Hassan ISA, et al
    Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    J Neurosurg. 2018 Jan 12:1-10. doi: 10.3171/2017.7.JNS17668.
    PubMed     Abstract available


  206. SUERO MOLINA E, Schipmann S, Mueller I, Wolfer J, et al
    Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients.
    J Neurosurg. 2018 Jan 12:1-8. doi: 10.3171/2017.7.JNS171312.
    PubMed     Abstract available


  207. PATIBANDLA MR, Lee CC, Tata A, Addagada GC, et al
    Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation.
    J Neurosurg. 2018 Jan 5:1-11. doi: 10.3171/2017.6.JNS17993.
    PubMed     Abstract available


  208. GOLDMAN DA, Hovinga K, Reiner AS, Esquenazi Y, et al
    The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
    J Neurosurg. 2018 Jan 5:1-9. doi: 10.3171/2017.6.JNS17393.
    PubMed     Abstract available


  209. DIAO K, Bian SX, Routman DM, Yu C, et al
    Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects.
    J Neurosurg. 2018 Jan 5:1-10. doi: 10.3171/2017.7.JNS171286.
    PubMed     Abstract available


    December 2017
  210. SHAN B, Zhang J, Xu J
    Letter to the Editor. Function outcome related to aggressive surgery for meningioma?
    J Neurosurg. 2017 Dec 22:1-2. doi: 10.3171/2017.6.JNS171089.
    PubMed    


  211. RINALDO L, Brown D, Lanzino G, Parney IF, et al
    Outcomes following cerebrospinal fluid shunting in high-grade glioma patients.
    J Neurosurg. 2017 Dec 22:1-13. doi: 10.3171/2017.6.JNS17859.
    PubMed     Abstract available


  212. MAYBERG M, Reintjes S, Patel A, Moloney K, et al
    Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    J Neurosurg. 2017 Dec 22:1-10. doi: 10.3171/2017.6.JNS17635.
    PubMed     Abstract available


  213. FERROLI P, Broggi M
    Letter to the Editor. Outcome prediction in brain tumor surgery.
    J Neurosurg. 2017 Dec 15:1-3. doi: 10.3171/2017.5.JNS171098.
    PubMed    


  214. PRASAD GL
    Letter to the Editor. Usefulness of 5-ALA in resection of intracranial meningiomas.
    J Neurosurg. 2017 Dec 1:1-3. doi: 10.3171/2017.6.JNS17634.
    PubMed    


  215. SHEEHAN JP
    Journal of Neurosurgery's Top 25 highly cited articles on Gamma Knife surgery for meningioma.
    J Neurosurg. 2017;127.
    PubMed    


    November 2017
  216. SHASBY G
    Erratum. Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases.
    J Neurosurg. 2017 Nov 24:1. doi: 10.3171/2017.8.JNS08268.
    PubMed    


  217. YAMAGUCHI F, Ten H, Higuchi T, Omura T, et al
    An intraoperative motor tract positioning method in brain tumor surgery: technical note.
    J Neurosurg. 2017 Nov 24:1-7. doi: 10.3171/2017.5.JNS162978.
    PubMed     Abstract available


  218. NEIL D
    Letter to the Editor. Puzzling posology: was the bevacizumab regimen in recurrent glioblastoma misreported?
    J Neurosurg. 2017 Nov 24:1. doi: 10.3171/2017.5.JNS171208.
    PubMed    


  219. OMAY SB, Almeida JP, Chen YN, Shetty SR, et al
    Is the chiasm-pituitary corridor size important for achieving gross-total resection during endonasal endoscopic resection of craniopharyngiomas?
    J Neurosurg. 2017 Nov 24:1-6. doi: 10.3171/2017.6.JNS163188.
    PubMed     Abstract available


  220. MAO L, Whitehead CA, Paradiso L, Kaye AH, et al
    Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.
    J Neurosurg. 2017 Nov 17:1-13. doi: 10.3171/2017.5.JNS17845.
    PubMed     Abstract available


  221. SOUTHWELL DG, Birk HS, Han SJ, Li J, et al
    Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.
    J Neurosurg. 2017 Nov 10:1-9. doi: 10.3171/2017.5.JNS17166.
    PubMed     Abstract available


  222. ZHENG SH, Huang JL, Chen M, Wang BL, et al
    Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    J Neurosurg. 2017 Nov 3:1-10. doi: 10.3171/2017.3.JNS161648.
    PubMed     Abstract available


    October 2017
  223. KIESEL B, Mischkulnig M, Woehrer A, Martinez-Moreno M, et al
    Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    J Neurosurg. 2017 Oct 27:1-13. doi: 10.3171/2017.4.JNS162991.
    PubMed     Abstract available


  224. POMERANIEC IJ, Kano H, Xu Z, Nguyen B, et al
    Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
    J Neurosurg. 2017 Oct 27:1-10. doi: 10.3171/2017.5.JNS163069.
    PubMed     Abstract available


  225. FIGUEROA JM, Carter BS
    Detection of glioblastoma in biofluids.
    J Neurosurg. 2017 Oct 20:1-7. doi: 10.3171/2017.3.JNS162280.
    PubMed     Abstract available


  226. CHATAIN GP, Patronas N, Smirniotopoulos JG, Piazza M, et al
    Potential utility of FLAIR in MRI-negative Cushing's disease.
    J Neurosurg. 2017 Oct 13:1-9. doi: 10.3171/2017.4.JNS17234.
    PubMed     Abstract available


  227. YUE Q, Yu Y, Shi Z, Wang Y, et al
    Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
    J Neurosurg. 2017 Oct 6:1-8. doi: 10.3171/2017.4.JNS163113.
    PubMed     Abstract available


  228. OPOKU-DARKO M, Lang ST, Artindale J, Cairncross JG, et al
    Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
    J Neurosurg. 2017 Oct 6:1-8. doi: 10.3171/2017.3.JNS17159.
    PubMed     Abstract available


  229. ROGERS L, Zhang P, Vogelbaum MA, Perry A, et al
    Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    J Neurosurg. 2017 Oct 6:1-13. doi: 10.3171/2016.11.JNS161170.
    PubMed     Abstract available


    September 2017
  230. ABEL TJ, Barrash J, Tranel D
    Letter to the Editor. Neuropsychological impairment and quality of life after skull base meningioma resection: size and location matter.
    J Neurosurg. 2017 Sep 29:1-2. doi: 10.3171/2017.4.JNS17740.
    PubMed    


  231. DHO YS, Kim YH, Se YB, Han DH, et al
    Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
    J Neurosurg. 2017 Sep 29:1-9. doi: 10.3171/2017.4.JNS162143.
    PubMed     Abstract available


  232. ANGELOV L, Mohammadi AM, Bennett EE, Abbassy M, et al
    Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases >/= 2 cm.
    J Neurosurg. 2017 Sep 22:1-17. doi: 10.3171/2017.3.JNS162532.
    PubMed     Abstract available


  233. FUJII Y, Muragaki Y, Maruyama T, Nitta M, et al
    Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    J Neurosurg. 2017 Sep 8:1-9. doi: 10.3171/2017.3.JNS162383.
    PubMed     Abstract available


  234. ALMEIDA JP, Omay SB, Shetty SR, Chen YN, et al
    Transorbital endoscopic eyelid approach for resection of sphenoorbital meningiomas with predominant hyperostosis: report of 2 cases.
    J Neurosurg. 2017 Sep 1:1-11. doi: 10.3171/2017.3.JNS163110.
    PubMed     Abstract available


  235. HIRAYAMA R, Kinoshita M, Arita H, Kagawa N, et al
    Voxel-based lesion mapping of meningioma: a comprehensive lesion location mapping of 260 lesions.
    J Neurosurg. 2017 Sep 1:1-6. doi: 10.3171/2017.3.JNS17169.
    PubMed     Abstract available


  236. MEHTA GU, Zenonos G, Patibandla MR, Lin CJ, et al
    Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study.
    J Neurosurg. 2017 Sep 1:1-7. doi: 10.3171/2017.3.JNS163008.
    PubMed     Abstract available


    August 2017
  237. ZUBATKINA I, Ivanov P
    Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
    J Neurosurg. 2017 Aug 25:1-12. doi: 10.3171/2017.1.JNS162075.
    PubMed     Abstract available


  238. SHAHAR T, Korn A, Barkay G, Biron T, et al
    Elaborate mapping of the posterior visual pathway in awake craniotomy.
    J Neurosurg. 2017 Aug 25:1-9. doi: 10.3171/2017.2.JNS162757.
    PubMed     Abstract available


  239. HUA L, Zhu H, Li J, Tang H, et al
    Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    J Neurosurg. 2017 Aug 18:1-9. doi: 10.3171/2017.2.JNS162566.
    PubMed     Abstract available


  240. BRAGSTAD S, Flatebo M, Natvig GK, Eide GE, et al
    Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    J Neurosurg. 2017 Aug 18:1-13. doi: 10.3171/2017.2.JNS161659.
    PubMed     Abstract available


  241. KALOSHI G, Petrela M
    Letter to the Editor. An extent of resection threshold for recurrent glioblastoma: why wait until recurrence?
    J Neurosurg. 2017 Aug 18:1. doi: 10.3171/2017.6.JNS14868.
    PubMed    


  242. KOTECHA R, Miller JA, Venur VA, Mohammadi AM, et al
    Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    J Neurosurg. 2017 Aug 11:1-10. doi: 10.3171/2017.1.JNS162797.
    PubMed     Abstract available


    July 2017
  243. OUSHY S, Sillau SH, Ney DE, Damek DM, et al
    New-onset seizure during and after brain tumor excision: a risk assessment analysis.
    J Neurosurg. 2017 Jul 28:1-6. doi: 10.3171/2017.2.JNS162315.
    PubMed     Abstract available


  244. LAU D, Hervey-Jumper SL, Han SJ, Berger MS, et al
    Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    J Neurosurg. 2017 Jul 21:1-9. doi: 10.3171/2017.1.JNS161811.
    PubMed     Abstract available


  245. PAVLOV V, Varlet P, Chretien F, Nguyen G, et al
    Letter to the Editor. Expression of tissue (pro)renin receptor and concentrations of its soluble form in CSF in adult diffuse gliomas.
    J Neurosurg. 2017 Jul 21:1-3. doi: 10.3171/2017.2.JNS17254.
    PubMed    


  246. TSERMOULAS G, Turel MK, Wilcox JT, Shultz D, et al
    Management of multiple meningiomas.
    J Neurosurg. 2017 Jul 21:1-7. doi: 10.3171/2017.2.JNS162608.
    PubMed     Abstract available


  247. ORTON A, Frandsen J, Jensen R, Shrieve DC, et al
    Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
    J Neurosurg. 2017 Jul 21:1-6. doi: 10.3171/2017.2.JNS162282.
    PubMed     Abstract available


  248. OMAY SB, Chen YN, Almeida JP, Ruiz-Trevino AS, et al
    Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    J Neurosurg. 2017 Jul 14:1-6. doi: 10.3171/2017.1.JNS162232.
    PubMed     Abstract available


  249. TURE H, Harput MV, Bekiroglu N, Keskin O, et al
    Effect of the degree of head elevation on the incidence and severity of venous air embolism in cranial neurosurgical procedures with patients in the semisitting position.
    J Neurosurg. 2017 Jul 14:1-10. doi: 10.3171/2017.1.JNS162489.
    PubMed     Abstract available


  250. CONNER AK, Burks JD, Baker CM, Smitherman AD, et al
    Method for temporal keyhole lobectomies in resection of low- and high-grade gliomas.
    J Neurosurg. 2017 Jul 7:1-8. doi: 10.3171/2016.12.JNS162168.
    PubMed     Abstract available


    June 2017
  251. MORSHED RA, Han SJ, Lau D, Berger MS, et al
    Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
    J Neurosurg. 2017 Jun 30:1-6. doi: 10.3171/2017.1.JNS161949.
    PubMed     Abstract available


  252. AKYERLI CB, Yuksel S, Can O, Erson-Omay EZ, et al
    Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    J Neurosurg. 2017 Jun 16:1-13. doi: 10.3171/2016.11.JNS16973.
    PubMed     Abstract available


  253. KIM D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, et al
    Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
    J Neurosurg. 2017 Jun 16:1-10. doi: 10.3171/2016.11.JNS16913.
    PubMed     Abstract available


  254. ESEONU CI, Eguia F, Garcia O, Kaplan PW, et al
    Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy.
    J Neurosurg. 2017 Jun 16:1-7. doi: 10.3171/2017.1.JNS162913.
    PubMed     Abstract available


  255. SHAH AH, Jusue-Torres I, Ivan ME, Komotar RJ, et al
    Pathogens and glioma: a history of unexpected discoveries ushering in novel therapy.
    J Neurosurg. 2017 Jun 9:1-8. doi: 10.3171/2016.12.JNS162123.
    PubMed     Abstract available


  256. MANDA SV, Kataria Y, Tatireddy BR, Ramakrishnan B, et al
    Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    J Neurosurg. 2017 Jun 2:1-11. doi: 10.3171/2016.11.JNS161187.
    PubMed     Abstract available


    May 2017
  257. XU DS, Awad AW, Mehalechko C, Wilson JR, et al
    An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    J Neurosurg. 2017 May 26:1-7. doi: 10.3171/2016.12.JNS161682.
    PubMed     Abstract available


  258. KIM K, Bang JY, Kim SO, Kim S, et al
    Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study.
    J Neurosurg. 2017 May 5:1-8. doi: 10.3171/2016.11.JNS162237.
    PubMed     Abstract available


  259. REN Q, He M, Xu J
    Letter to the Editor. Does preoperative NLR predict brain metastasis resections outcome?
    J Neurosurg. 2017 May 5. doi: 10.3171/2016.12.JNS163096.
    PubMed    


  260. MURATA D, Mineharu Y, Arakawa Y, Liu B, et al
    High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma.
    J Neurosurg. 2017 May 5:1-7. doi: 10.3171/2016.11.JNS16991.
    PubMed     Abstract available


    April 2017
  261. SAITO T, Sugiyama K, Takeshima Y, Amatya VJ, et al
    Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    J Neurosurg. 2017 Apr 21:1-6. doi: 10.3171/2016.11.JNS162326.
    PubMed     Abstract available


  262. COTE DJ, Balak N, Brennum J, Holsgrove DT, et al
    Ethical difficulties in the innovative surgical treatment of patients with recurrent glioblastoma multiforme.
    J Neurosurg. 2017 Apr 21:1-6. doi: 10.3171/2016.11.JNS162488.
    PubMed    


  263. WANG W, Cho HY, Rosenstein-Sisson R, Marin Ramos NI, et al
    Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.
    J Neurosurg. 2017 Apr 14:1-6. doi: 10.3171/2016.11.JNS161212.
    PubMed     Abstract available


  264. LEE JY, Pierce JT, Thawani JP, Zeh R, et al
    Near-infrared fluorescent image-guided surgery for intracranial meningioma.
    J Neurosurg. 2017 Apr 7:1-11. doi: 10.3171/2016.10.JNS161636.
    PubMed     Abstract available


  265. YAO PS, Zheng SF, Wang F, Kang DZ, et al
    Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
    J Neurosurg. 2017 Apr 7:1-6. doi: 10.3171/2016.11.JNS161296.
    PubMed     Abstract available


  266. MARX S, Clemens S, Schroeder HW
    The value of endoscope assistance during transcranial surgery for tuberculum sellae meningiomas.
    J Neurosurg. 2017 Apr 7:1-8. doi: 10.3171/2016.11.JNS16713.
    PubMed     Abstract available


  267. GESSLER F, Bruder M, Duetzmann S, Tritt S, et al
    Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors.
    J Neurosurg. 2017 Apr 7:1-7. doi: 10.3171/2016.11.JNS161871.
    PubMed     Abstract available


    March 2017
  268. KARSY M, Burnett B, Di Ieva A, Cusimano MD, et al
    Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
    J Neurosurg. 2017 Mar 31:1-10. doi: 10.3171/2016.10.JNS161825.
    PubMed     Abstract available


  269. THOMAS JG, Parker Kerrigan BC, Hossain A, Gumin J, et al
    Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    J Neurosurg. 2017 Mar 31:1-9. doi: 10.3171/2016.9.JNS16278.
    PubMed     Abstract available


  270. KOLAKSHYAPATI M, Adhikari RB, Karlowee V, Takayasu T, et al
    Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    J Neurosurg. 2017 Mar 31:1-12. doi: 10.3171/2016.10.JNS161694.
    PubMed     Abstract available


  271. TULEASCA C, Negretti L, Faouzi M, Magaddino V, et al
    Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
    J Neurosurg. 2017 Mar 24:1-10. doi: 10.3171/2016.10.JNS161480.
    PubMed     Abstract available


  272. COHEN-INBAR O, Tata A, Moosa S, Lee CC, et al
    Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation.
    J Neurosurg. 2017 Mar 24:1-11. doi: 10.3171/2016.11.JNS161402.
    PubMed     Abstract available


  273. SUERO MOLINA E, Wolfer J, Ewelt C, Ehrhardt A, et al
    Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
    J Neurosurg. 2017 Mar 24:1-7. doi: 10.3171/2016.11.JNS161072.
    PubMed     Abstract available


  274. TIETZE A, Choi C, Mickey B, Maher EA, et al
    Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
    J Neurosurg. 2017 Mar 3:1-8. doi: 10.3171/2016.10.JNS161793.
    PubMed     Abstract available


  275. PEETERS S, Pages M, Gauchotte G, Miquel C, et al
    Interactions between glioma and pregnancy: insight from a 52-case multicenter series.
    J Neurosurg. 2017 Mar 3:1-11. doi: 10.3171/2016.10.JNS16710.
    PubMed     Abstract available


  276. FLORMAN JE, Cushing D, Keller LA, Rughani AI, et al
    A protocol for postoperative admission of elective craniotomy patients to a non-ICU or step-down setting.
    J Neurosurg. 2017 Mar 3:1-6. doi: 10.3171/2016.10.JNS16954.
    PubMed     Abstract available


    February 2017
  277. MITTAL S, Klinger NV, Michelhaugh SK, Barger GR, et al
    Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
    J Neurosurg. 2017 Feb 24:1-8. doi: 10.3171/2016.9.JNS16452.
    PubMed     Abstract available


  278. MASTORAKOS P, Hays MA, Caruso JP, Chen CJ, et al
    Transtentorial dissemination of optic nerve glioblastoma: case report.
    J Neurosurg. 2017 Feb 17:1-8. doi: 10.3171/2016.10.JNS161443.
    PubMed     Abstract available


  279. WOLF A, Kvint S, Chachoua A, Pavlick A, et al
    Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
    J Neurosurg. 2017 Feb 17:1-9. doi: 10.3171/2016.10.JNS161036.
    PubMed     Abstract available


  280. DENG L, Zhou H, Xiao B, Bai HX, et al
    Letter to the Editor: Specificity and validity of putaminal involvement as a prognostic factor in Grade II insular gliomas.
    J Neurosurg. 2017 Feb 10:1-2. doi: 10.3171/2016.9.JNS162311.
    PubMed    


  281. ZWECKBERGER K, Hallek E, Vogt L, Giese H, et al
    Prospective analysis of neuropsychological deficits following resection of benign skull base meningiomas.
    J Neurosurg. 2017 Feb 10:1-7. doi: 10.3171/2016.10.JNS161936.
    PubMed     Abstract available


  282. D'AMICO RS, Banu MA, Petridis P, Bercow AS, et al
    Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas.
    J Neurosurg. 2017 Feb 10:1-11. doi: 10.3171/2016.10.JNS161982.
    PubMed     Abstract available


  283. GATTERBAUER B, Gevsek S, Hoftberger R, Lutgendorf-Caucig C, et al
    Multimodal treatment of parasagittal meningiomas: a single-center experience.
    J Neurosurg. 2017 Feb 3:1-8. doi: 10.3171/2016.9.JNS161859.
    PubMed     Abstract available


    January 2017
  284. BANDER ED, Singh H, Ogilvie CB, Cusic RC, et al
    Endoscopic endonasal versus transcranial approach to tuberculum sellae and planum sphenoidale meningiomas in a similar cohort of patients.
    J Neurosurg. 2017 Jan 27:1-9. doi: 10.3171/2016.9.JNS16823.
    PubMed     Abstract available


  285. JEHNA M, Becker J, Zaar K, von Campe G, et al
    Symmetry of the arcuate fasciculus and its impact on language performance of patients with brain tumors in the language-dominant hemisphere.
    J Neurosurg. 2017 Jan 27:1-10. doi: 10.3171/2016.9.JNS161281.
    PubMed     Abstract available


  286. CONWAY N, Wildschuetz N, Moser T, Bulubas L, et al
    Cortical plasticity of motor-eloquent areas measured by navigated transcranial magnetic stimulation in patients with glioma.
    J Neurosurg. 2017 Jan 20:1-11. doi: 10.3171/2016.9.JNS161595.
    PubMed     Abstract available


  287. KANO H, Morales-Restrepo A, Iyer A, Weiner GM, et al
    Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
    J Neurosurg. 2017 Jan 20:1-9. doi: 10.3171/2016.9.JNS161011.
    PubMed     Abstract available


  288. LEE EJ, Kim JH, Park ES, Kim YH, et al
    A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas.
    J Neurosurg. 2017 Jan 13:1-10. doi: 10.3171/2016.9.JNS161669.
    PubMed     Abstract available


  289. TAKAKURA T, Muragaki Y, Tamura M, Maruyama T, et al
    Navigated transcranial magnetic stimulation for glioma removal: prognostic value in motor function recovery from postsurgical neurological deficits.
    J Neurosurg. 2017 Jan 6:1-15. doi: 10.3171/2016.8.JNS16442.
    PubMed     Abstract available


  290. COHEN-INBAR O, Shih HH, Xu Z, Schlesinger D, et al
    The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab.
    J Neurosurg. 2017 Jan 6:1-8. doi: 10.3171/2016.9.JNS161585.
    PubMed     Abstract available


  291. MISSIOS S, Bekelis K
    Emergency department evaluation and 30-day readmission after craniotomy for primary brain tumor resection in New York State.
    J Neurosurg. 2017 Jan 6:1-6. doi: 10.3171/2016.9.JNS161575.
    PubMed     Abstract available


  292. SOUTHWELL DG, Riva M, Jordan K, Caverzasi E, et al
    Language outcomes after resection of dominant inferior parietal lobule gliomas.
    J Neurosurg. 2017 Jan 6:1-9. doi: 10.3171/2016.8.JNS16443.
    PubMed     Abstract available


  293. PRIETO R, Pascual JM
    Norman M. Dott, master of hypothalamic craniopharyngioma surgery: the decisive mentoring of Harvey Cushing and Percival Bailey at Peter Bent Brigham Hospital.
    J Neurosurg. 2017 Jan 6:1-14. doi: 10.3171/2016.9.JNS16702.
    PubMed     Abstract available


  294. BIJANGI-VISHEHSARAEI K, Reza Saadatzadeh M, Wang H, Nguyen A, et al
    Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
    J Neurosurg. 2017 Jan 6:1-12. doi: 10.3171/2016.8.JNS161197.
    PubMed     Abstract available


  295. KOUCHI M, Shibayama Y, Ogawa D, Miyake K, et al
    (Pro)renin receptor is crucial for glioma development via the Wnt/beta-catenin signaling pathway.
    J Neurosurg. 2017 Jan 6:1-10. doi: 10.3171/2016.9.JNS16431.
    PubMed     Abstract available


  296. MEIER R, Porz N, Knecht U, Loosli T, et al
    Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma.
    J Neurosurg. 2017 Jan 6:1-9. doi: 10.3171/2016.9.JNS16146.
    PubMed     Abstract available


  297. MOTOMURA K, Natsume A, Iijima K, Kuramitsu S, et al
    Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas.
    J Neurosurg. 2017 Jan 6:1-8. doi: 10.3171/2016.9.JNS16152.
    PubMed     Abstract available


    December 2016
  298. SHRIVASTAVA A, Arora P, Khare A, Goel G, et al
    Central nervous system filariasis masquerading as a glioma: case report.
    J Neurosurg. 2016 Dec 23:1-3. doi: 10.3171/2016.9.JNS161092.
    PubMed     Abstract available


  299. SRINIVASAN A
    Letter to the Editor: Recurrent or residual craniopharyngioma: management options.
    J Neurosurg. 2016 Dec 23:1. doi: 10.3171/2016.9.JNS162481.
    PubMed    


  300. GRAILLON T, Romano D, Defilles C, Saveanu A, et al
    Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review.
    J Neurosurg. 2016.
    PubMed     Abstract available


  301. RAHEJA A, Colman H, Palmer CA, Couldwell WT, et al
    Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report.
    J Neurosurg. 2016.
    PubMed     Abstract available


  302. CHEN YR, Ugiliweneza B, Burton E, Woo SY, et al
    The effect of postoperative infection on survival in patients with glioblastoma.
    J Neurosurg. 2016.
    PubMed     Abstract available


  303. SERIZAWA T, Higuchi Y, Nagano O, Matsuda S, et al
    Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery.
    J Neurosurg. 2016.
    PubMed     Abstract available


  304. MITSUYA K, Nakasu Y, Kurakane T, Hayashi N, et al
    Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
    J Neurosurg. 2016.
    PubMed     Abstract available


  305. DONG P, Perez-Andujar A, Pinnaduwage D, Braunstein S, et al
    Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  306. DUMA CM, Kim BS, Chen PV, Plunkett ME, et al
    Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  307. LESTER-COLL NH, Dosoretz AP, Magnuson WJ, Laurans MS, et al
    Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  308. SPECKTER H, Bido J, Hernandez G, Mejia DR, et al
    Prognostic value of diffusion tensor imaging parameters for Gamma Knife radiosurgery in meningiomas.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  309. VALERY CA, Faillot M, Lamproglou I, Golmard JL, et al
    Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  310. MIX M, Elmarzouky R, O'Connor T, Plunkett R, et al
    Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  311. EL-SHEHABY AM, Reda WA, Abdel Karim KM, Emad Eldin RM, et al
    Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  312. BIAN SX, Routman D, Liu J, Yang D, et al
    Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  313. KAWABE T, Yamamoto M, Sato Y, Yomo S, et al
    Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
    J Neurosurg. 2016;125.
    PubMed     Abstract available


  314. KOISO T, Yamamoto M, Kawabe T, Watanabe S, et al
    Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
    J Neurosurg. 2016;125.
    PubMed     Abstract available


    November 2016
  315. STRICKLAND MR, Gill CM, Nayyar N, D'Andrea MR, et al
    Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.
    J Neurosurg. 2016.
    PubMed     Abstract available


  316. JOHN JK, Robin AM, Pabaney AH, Rammo RA, et al
    Complications of ventricular entry during craniotomy for brain tumor resection.
    J Neurosurg. 2016.
    PubMed     Abstract available


    October 2016
  317. ZHANG JT
    Erratum: Foramen magnum meningiomas: surgical results and risks predicting poor outcomes based on a modified classification.
    J Neurosurg. 2016.
    PubMed    


  318. BETTE S, Gempt J, Huber T, Delbridge C, et al
    FLAIR signal increase of the fluid within the resection cavity after glioma surgery: generally valid as early recurrence marker?
    J Neurosurg. 2016.
    PubMed     Abstract available


  319. VAIOS EJ, Nahed BV, Muzikansky A, Fathi AT, et al
    Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.
    J Neurosurg. 2016.
    PubMed     Abstract available


  320. NEIRA JA, Ung TH, Sims JS, Malone HR, et al
    Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
    J Neurosurg. 2016.
    PubMed     Abstract available


  321. CHERNOV M
    Letter to the Editor: Seizures and invasive meningiomas.
    J Neurosurg. 2016.
    PubMed    


  322. WOLF A, Coros A, Bierer J, Goncalves S, et al
    Quantitative evaluation of vision-related and health-related quality of life after endoscopic transsphenoidal surgery for pituitary adenoma.
    J Neurosurg. 2016.
    PubMed     Abstract available


    September 2016
  323. RAHMAN M, Abbatematteo J, De Leo EK, Kubilis PS, et al
    The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
    J Neurosurg. 2016.
    PubMed     Abstract available


  324. AZARNOUSH H, Siar S, Sawaya R, Zhrani GA, et al
    The force pyramid: a spatial analysis of force application during virtual reality brain tumor resection.
    J Neurosurg. 2016.
    PubMed     Abstract available


  325. BURKS JD, Bonney PA, Conner AK, Glenn CA, et al
    A method for safely resecting anterior butterfly gliomas: the surgical anatomy of the default mode network and the relevance of its preservation.
    J Neurosurg. 2016.
    PubMed     Abstract available


  326. BANSAL A, Sinha S
    Letter to the Editor: Resection of olfactory groove meningiomas.
    J Neurosurg. 2016.
    PubMed    


  327. BAGSHAW HP, Burt LM, Jensen RL, Suneja G, et al
    Adjuvant radiotherapy for atypical meningiomas.
    J Neurosurg. 2016.
    PubMed     Abstract available


    May 2016
  328. KRISHT KM, Palmer CA, Couldwell WT
    Multiple osteomas of the falx cerebri and anterior skull base: case report.
    J Neurosurg. 2016;124:1339-42.
    PubMed     Abstract available


  329. ZOU Z, Yin Y, Lin J, Hsu LC, et al
    Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3.
    J Neurosurg. 2016;124:1310-8.
    PubMed     Abstract available


  330. FAUST K, Vajkoczy P
    Distinct displacements of the optic radiation based on tumor location revealed using preoperative diffusion tensor imaging.
    J Neurosurg. 2016;124:1343-52.
    PubMed     Abstract available


    March 2016
  331. LITTLE AS, Kelly DF, Barkhoudarian G
    Letter to the Editor: Transsphenoidal surgery for nonfunctioning adenomas.
    J Neurosurg. 2016.
    PubMed    


  332. TAMURA Y, Ogawa H, Kapeller C, Prueckl R, et al
    Passive language mapping combining real-time oscillation analysis with cortico-cortical evoked potentials for awake craniotomy.
    J Neurosurg. 2016.
    PubMed     Abstract available


  333. MOON JH, Kim EH, Kim SH
    Snare technique for the remodeling of the redundant arachnoid pouch to prevent cerebrospinal fluid rhinorrhea and hematoma collection during transsphenoidal surgery for suprasellar-extended pituitary tumors.
    J Neurosurg. 2016.
    PubMed     Abstract available


    December 2015
  334. PLEDGER CL, Elzoghby MA, Oldfield EH, Payne SC, et al
    Prospective comparison of sinonasal outcomes after microscopic sublabial or endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenomas.
    J Neurosurg. 2015.
    PubMed     Abstract available


    November 2015
  335. TERPOLILLI NA, Rachinger W, Kunz M, Thon N, et al
    Orbit-associated tumors: navigation and control of resection using intraoperative computed tomography.
    J Neurosurg. 2015.
    PubMed     Abstract available


  336. SOUTHWELL DG, Hervey-Jumper SL, Perry DW, Berger MS, et al
    Intraoperative mapping during repeat awake craniotomy reveals the functional plasticity of adult cortex.
    J Neurosurg. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: